Publications by authors named "David M Parry"

Claim this Profile
C
Closing the Loop: Developing an Integrated Design, Make, and Test Platform for Discovery.
David M Parry

ACS Med Chem Lett· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Synthesis and Testing of Substituted Xanthine Based DPP4 Inhibitors: Application to Drug Discovery.
Werngard Czechtizky, Jüergen Dedio, Bimbisar Desai, Karen Dixon, Elizabeth Farrant, David M Parry

ACS Med Chem Lett· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platform.
Bimbisar Desai, Karen Dixon, Elizabeth Farrant, Qixing Feng, Karl R Gibson, David M Parry

J Med Chem· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heteroaromatic rings of the future.
William R Pitt, David M Parry, Benjamin G Perry, Colin R Groom

J Med Chem· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IRAK-4 inhibitors. Part 1: a series of amides.
George M Buckley, Lewis Gowers, Alicia Perez Higueruelo, Kerry Jenkins, Stephen R Mack, David M Parry

Bioorg Med Chem Lett· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine binding.
George M Buckley, Thomas A Ceska, Joanne L Fraser, Lewis Gowers, Colin R Groom, David M Parry

Bioorg Med Chem Lett· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationship of aminopyrimidine IKK2 inhibitors.
Alistair H Bingham, Richard J Davenport, Richard Fosbeary, Lewis Gowers, Roland L Knight, David M Parry

Bioorg Med Chem Lett· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IRAK-4 inhibitors. Part III: a series of imidazo[1,2-a]pyridines.
George M Buckley, Richard Fosbeary, Joanne L Fraser, Lewis Gowers, Alicia P Higueruelo, David M Parry

Bioorg Med Chem Lett· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of single-value protein compensation of the Jaffe creatinine assay contributes to clinically significant inaccuracy in results.
David M Parry

Clin Chem· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel series of potent and selective IKK2 inhibitors.
Alistair H Bingham, Richard J Davenport, Lewis Gowers, Roland L Knight, Christopher Lowe, David M Parry

Bioorg Med Chem Lett· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solid-phase synthesis of imidazo[4,5-b]pyridin-2-ones and related urea derivatives by cyclative cleavage of a carbamate linkage.
Monika Ermann, Nadja M Simkovsky, Stanley M Roberts, David M Parry, Andy D Baxter

J Comb Chem· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A solid-phase route to N-cyanoamides.
Trevor Morgan, Nicholas C Ray, David M Parry

Org Lett· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis